| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
The Hanover Insurance Group, Inc. (THG) has 18 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. THG is classified in the Insurance industry within the Financials sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 123.8K | $22.94M | - | |
| VP | 45.9K | $8.50M | - | |
| VP | 39.2K | $7.25M | - | |
| Dir | 33.0K | $6.11M | - | |
| VP | 25.7K | $4.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Egan Cynthia | Director | Sell | 3,400 | $188.50 | $640,900.00 | -26.6% | - | - | |
| Nov 12, 2025 | Lowsley Denise | Executive Vice President | Sell | 1,619 | $181.47 | $293,799.93 | -31.6% | -4.4% | - | |
| Aug 1, 2025 | Lowsley Denise | Executive Vice President | Sale+OE | 5,626 | $168.15 | $946,011.90 | -52.4% | +0.8% | - | |
| May 23, 2025 | Carlin Jane D45 | Director | Sell | 977 | $167.81 | $163,950.37 | -100% | +3.3% | - | |
| May 7, 2025 | Salvatore Bryan J | Executive Vice President | Sale+OE | 10,526 | $166.60 | $1,753,605.01 | -11.2% | +2.5% | - | |
| Apr 1, 2025 | Roche John C76 | President And CEO | Sale+OE | 8,906 | $175.17 | $1,560,064.02 | -6.7% | -2.9% | -1.5% | |
| Mar 31, 2025 | Roche John C76 | President And CEO | Sale+OE | 701 | $175.02 | $122,687.00 | -0.3% | -2.3% | -0.3% | |
| Mar 27, 2025 | Roche John C76 | President And CEO | Sale+OE | 1,100 | $175.14 | $192,655.00 | -0.4% | -5.1% | -3.0% | |
| Mar 3, 2025 | Salvatore Bryan J | Executive Vice President | Sale+OE | 10,526 | $172.10 | $1,811,530.90 | -10.3% | +2.9% | +3.6% | |
| Mar 3, 2025 | Roche John C76 | President And CEO | Sale+OE | 10,706 | $172.10 | $1,842,541.06 | -2.7% | +2.9% | +3.6% |